太极集团：拟合计受让桐君阁中药批发100%股权 斥资2343万元

Core Viewpoint - The company intends to acquire a total of 90% and 10% stakes in Chongqing Tongjun Pavilion Traditional Chinese Medicine Wholesale Co., Ltd. for cash amounts of 21.08 million yuan and 2.35 million yuan, respectively, from its subsidiaries, which will not affect the financial and operational status of the company [1] Group 1 - The company will acquire 90% of the shares from Chongqing Chinese Medicinal Materials Co., Ltd. for 21.08 million yuan [1] - The company will also acquire 10% of the shares from Taiji Group Chongqing Fuling Pharmaceutical Co., Ltd. for 2.35 million yuan [1] - The share transfers are internal transactions between the company and its subsidiaries, not involving external shareholders [1] Group 2 - The transactions will not lead to changes in the company's consolidated financial statements [1] - There will be no adverse impact on the company's financial and operational conditions as a result of these acquisitions [1]